Abstract The rapid rise of particle therapy across the world necessitates evidence to justify its ever-increasing utilization. This narrative review summarizes the current status of these technologies on treatment of both meningiomas and gliomas. the most common benign and malignant primary brain tumors. respectively. https://spencertifieders.shop/product-category/cables/